|
Regina Hodits is a Partner in the life sciences sector, and joined Atlas Venture in 2004.
She began her career in venture capital in 2000 with Apax Partners in Munich, where she was responsible for life science investments in the German speaking region. Prior to Apax Partners, she was an industry specialist for pharmaceutical and biotech companies at McKinsey & Company focusing on spin-offs and mergers in the sector.
Regina currently serves on the Boards of Atlas Venture portfolio companies Egalet, Fibrex, F-Star, Jenavalve and U3 Pharma.
Regina holds a Ph.D. in Biochemistry and a Master of Science from the Technical University in Vienna, Austria. She did post doctoral research at MRC in Cambridge, UK and has been published in several journals, including Nature Biotech and JBC.
Investment Sector : Life Sciences
Boards :
Egalet, f-star, Fibrex, JenaValve, U3 Pharma
In the News:
Danish Biotech Company Egalet Strengthens Management by Appointing Internationally Experienced CFO | 